首页> 美国卫生研究院文献>other >Locked Nucleic Acid Probe-Based Real-Time PCR Assay for the Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis
【2h】

Locked Nucleic Acid Probe-Based Real-Time PCR Assay for the Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis

机译:基于锁定核酸探针的实时荧光定量PCR快速检测耐利福平的结核分枝杆菌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug-resistant Mycobacterium tuberculosis can be rapidly diagnosed through nucleic acid amplification techniques by analyzing the variations in the associated gene sequences. In the present study, a locked nucleic acid (LNA) probe-based real-time PCR assay was developed to identify the mutations in the rpoB gene associated with rifampin (RFP) resistance in M. tuberculosis. Six LNA probes with the discrimination capability of one-base mismatch were designed to monitor the 23 most frequent rpoB mutations. The target mutations were identified using the probes in a “probe dropout” manner (quantification cycle = 0); thus, the proposed technique exhibited superiority in mutation detection. The LNA probe-based real-time PCR assay was developed in a two-tube format with three LNA probes and one internal amplification control probe in each tube. The assay showed excellent specificity to M. tuberculosis with or without RFP resistance by evaluating 12 strains of common non-tuberculosis mycobacteria. The limit of detection of M. tuberculosis was 10 genomic equivalents (GE)/reaction by further introducing a nested PCR method. In a blind validation of 154 clinical mycobacterium isolates, 142/142 (100%) were correctly detected through the assay. Of these isolates, 88/88 (100%) were determined as RFP susceptible and 52/54 (96.3%) were characterized as RFP resistant. Two unrecognized RFP-resistant strains were sequenced and were found to contain mutations outside the range of the 23 mutation targets. In conclusion, this study established a sensitive, accurate, and low-cost LNA probe-based assay suitable for a four-multiplexing real-time PCR instrument. The proposed method can be used to diagnose RFP-resistant tuberculosis in clinical laboratories.
机译:通过分析相关基因序列的变异,可以通过核酸扩增技术快速诊断出耐药结核分枝杆菌。在本研究中,开发了基于锁定核酸(LNA)探针的实时PCR分析方法,以鉴定与结核分枝杆菌中的利福平(RFP)耐药性相关的rpoB基因突变。设计了六种具有一碱基错配识别能力的LNA探针,以监测23个最常见的rpoB突变。使用探针以“探针缺失”方式鉴定靶突变(定量循环= 0);因此,所提出的技术在突变检测方面显示出优越性。基于LNA探针的实时PCR分析是以两管形式开发的,每管中有三个LNA探针和一个内部扩增对照探针。通过评估12种常见的非结核分枝杆菌菌株,该试验对有或没有RFP耐药性的结核分枝杆菌均​​显示出优异的特异性。通过进一步引入巢式PCR方法,结核分枝杆菌的检出限为10个基因组当量(GE)/反应。在对154种临床分枝杆菌的盲目验证中,通过检测正确地检测到142/142(100%)。在这些分离物中,有88/88(100%)被确定为RFP易感者,而52/54(96.3%)被确定为具有RFP抗性。对两个无法识别的RFP耐药菌株进行了测序,发现它们包含23个突变靶标范围之外的突变。总之,这项研究建立了一种灵敏,准确且低成本的基于LNA探针的测定方法,适用于四重实时PCR仪。该方法可用于临床实验室对RFP耐药的结核病的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号